Isolation of tumorigenic circulating melanoma cells

Frank, 2010, The therapeutic promise of the cancer stem cell concept, J. Clin. Invest., 120, 41, 10.1172/JCI41004 Ma, 2010, Tumor initiation in human malignant melanoma and potential cancer therapies, Anticancer Agents Med. Chem., 10, 131, 10.2174/187152010790909254 Schatton, 2008, Cancer stem cells and human malignant melanoma, Pigm. Cell Melanoma Res., 21, 39, 10.1111/j.1755-148X.2007.00427.x Fidler, 2003, The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited, Nat. Rev. Cancer, 3, 453, 10.1038/nrc1098 Pantel, 2008, Detection, clinical relevance and specific biological properties of disseminating tumour cells, Nat. Rev. Cancer, 8, 329, 10.1038/nrc2375 Smith, 1991, Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction, Lancet, 338, 1227, 10.1016/0140-6736(91)92100-G Mocellin, 2006, The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis, Clin. Cancer Res., 12, 4605, 10.1158/1078-0432.CCR-06-0823 Koyanagi, 2010, Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma, Clin. Cancer Res., 16, 2402, 10.1158/1078-0432.CCR-10-0037 Medic, 2007, Molecular markers of circulating melanoma cells, Pigm. Cell Res., 20, 80, 10.1111/j.1600-0749.2006.00356.x Schatton, 2008, Identification of cells initiating human melanomas, Nature, 451, 345, 10.1038/nature06489 Boiko, 2010, Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271, Nature, 466, 133, 10.1038/nature09161 Sharma, 2010, Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease, J. Surg. Res., 1 Gazzaniga, 2010, CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients, Eur. J. Surg. Oncol., 10.1016/j.ejso.2010.05.001 Cheung, 2010, Granulin–Epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance, Gastroenterology Frank, 2005, ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma, Cancer Res., 65, 4320, 10.1158/0008-5472.CAN-04-3327 Schatton, 2010, Modulation of T-cell activation by malignant melanoma initiating cells, Cancer Res., 70, 697, 10.1158/0008-5472.CAN-09-1592 Seftor, 1993, The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion, Cancer Res., 53, 3411 Thies, 2007, Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice, Br. J. Cancer, 96, 609, 10.1038/sj.bjc.6603594 Frank, 2003, Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter, J. Biol. Chem., 278, 47156, 10.1074/jbc.M308700200 Izawa, 2010, A novel in vivo regulatory role of P-glycoprotein in alloimmunity, Biochem. Biophys. Res. Commun., 394, 646, 10.1016/j.bbrc.2010.03.040 Frank, 2001, Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro, J. Immunol., 166, 2451, 10.4049/jimmunol.166.4.2451 Fukunaga-Kalabis, 2010, Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population, Oncogene, 10.1038/onc.2010.350 Chambers, 2002, Dissemination and growth of cancer cells in metastatic sites, Nat. Rev. Cancer, 2, 563, 10.1038/nrc865 Steeg, 2006, Tumor metastasis: mechanistic insights and clinical challenges, Nat. Med., 12, 895, 10.1038/nm1469 Kim, 2009, Tumor self-seeding by circulating cancer cells, Cell, 139, 1315, 10.1016/j.cell.2009.11.025 Samija, 2010, Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma, Melanoma Res.